Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 25 Feb 2025 for Singular Genomics Systems, Inc.. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
No signal scores available.
Dalen Meeter: trading record in brief
Dalen Meeter discloses dealings in Singular Genomics Systems, Inc. to SEC (Form 4). We count 12 filings; the first trade dates from 15 June 2023 and the latest from 21 February 2025.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The record was last updated on 25 February 2025 with a transaction in Singular Genomics Systems, Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Dalen Meeter
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations12 total
9,502 sharesCommon StockSEC:0000950170-25-027107:0
500 sharesCommon StockSEC:0000950170-25-018146:0
209 sharesCommon StockSEC:0000950170-24-137421:0
500 sharesCommon StockSEC:0000950170-24-126423:0
209 sharesCommon StockSEC:0000950170-24-107504:0
500 sharesCommon StockSEC:0000950170-24-096422:0
6,250 sharesCommon StockSEC:0000950170-24-075038:0
15,000 sharesCommon StockSEC:0000950170-24-058958:0
6,250 sharesCommon StockSEC:0001209191-24-004952:0
6,250 sharesCommon StockSEC:0001209191-23-059008:0
6,250 sharesCommon StockSEC:0001209191-23-049654:0
6,250 sharesCommon StockSEC:0001209191-23-038490:0
12 of 12 declarations
